Windtree Therapeutics logo
Windtree Therapeutics WINT
$ 0.5 -1.65%

Quarterly report 2024-Q2
added 08-19-2024

report update icon

Windtree Therapeutics Financial Ratios 2011-2024 | WINT

Annual Financial Ratios Windtree Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.1 -0.0 -2.7 -5.0 -0.9 -0.2 -0.3 -0.3 -8.1 -8.4 -7.0 -7.0

P/S

- - - - 695.4 10.8 3.1 5.4 16.8 125.2 973.5 1305.4 253.7

EPS

-5.2 -62.2 -136.6 -2.1 -2.5 -7.7 -24.1 -4.7 -8.0 -7.3 -0.8 -0.9 -0.9

EV (Enterprise Value)

26.4 M 24.9 M 11.1 M 114 M 159 M 59.5 M 30 M 43.9 M 14 M 338 M 324 M 246 M 149 M

EBITDA per Share

-5.29 -64.8 -156 -2.06 -2.42 -12.9 -48.2 -272 -438 -140 -219 -262 -291

EV/EBITDA

-0.5 -2.3 -5.1 -1.6 -1.1 -0.8 -0.1 -7.8 -7.1 -6.4 -5.9

PEG

-0.0 -0.0 -0.0 -0.16 -0.06 -0.01 -0.0 -0.01 0.0 -0.22 -0.55 4.12 -0.15

P/B

0.5 0.3 0.0 1.3 1.8 0.3 -0.2 -0.4 2.0 18.5 6.5 14.8 116.4

P/CF

-0.1 -0.2 -0.0 -3.4 -5.5 -1.2 -0.2 -0.3 -0.5 -8.5 -9.2 -7.8 -6.5

ROE %

-598.38 -391.61 -161.50 -46.82 -36.67 -30.15 77.12 136.98 -667.43 -229.48 -77.30 -211.41 -1659.02

ROA %

-62.61 -103.30 -90.44 -28.85 -23.09 -17.20 -551.12 -407.16 -124.32 -92.76 -50.64 -124.82 -157.67

ROCE %

-607.40 -412.83 -184.52 -28.40 -24.01 -19.78 198.79 1030.23 -154.89 -109.04 -57.51 -207.80 -1114.09

Current Ratio

1.1 1.4 2.3 3.0 3.1 1.2 0.2 0.5 3.7 5.8 7.3 2.4 1.0

DSO

- - - - - - - - - - 93.6 - -

DIO

- - - - - - - - - - 70.2 44.2 -

DPO

- - - - - - - - 145.0 - 982.7 265.5 -

Operating Cycle

- - - - - - - - - - 163.8 44.2 -

Cash Conversion Cycle

- - - - - - - - -145.0 - -818.9 -221.2 -

All numbers in USD currency

Quarterly Financial Ratios Windtree Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-20.91 21.98 - -0.86 -29.47 -85.65 - -6.51 -29.68 -14.36 - -0.31 -1.42 -0.51 - -0.54 -0.63 -0.48 -0.21 -0.66 -0.6 -0.61 -3.24 -1.04 -0.81 -1.4 1.03 -10.53 -14.37 -27.4 -0.77 -1 -1.29 -1.7 -1.26 -2.8 -1.82 -1.96 -1.68 -1.82 -1.68 -1.96 -0.16 -0.22 -0.18 -0.29 -0.16 -0.31 -0.16 -0.37 -0.18 -0.2 -0.34 -0.21

EBITDA per Share

- -9.43 - - - -86.8 - -6.65 -29.2 -13.9 - -0.3 -1.72 -0.51 - -0.52 -0.52 -0.49 -0.13 -0.65 -0.59 -0.62 -0.67 -0.89 -0.79 -1.49 -1.45 -6.58 -11.9 -17.9 -0.75 -0.9 -1.2 -1.69 -1.22 -1.04 -1.61 -1.76 -1.84 -1.6 -1.74 -1.75 -0.14 -0.19 -0.21 -0.28 -0.29 -0.21 -0.19 -0.23 -243 -216 -239 -317

ROE %

-396.12 -108.87 -174.50 -197.78 -161.94 -195.34 -136.97 -153.34 -146.43 -122.00 -92.03 -105.00 -101.60 -49.47 -36.11 -45.95 -42.49 -37.34 -36.67 -40.10 -36.35 -32.24 -30.15 -27.21 1.31 34.02 77.12 110.35 116.61 125.23 136.98 -8.22 -298.01 -471.88 -667.43 -600.53 -398.73 -317.05 -229.48 -194.14 -156.05 -115.47 -77.29 -95.85 -150.55 -176.24 -211.38 -513.04 -813.31 -1411.80 -1658.62 -375.87 -638.92 -303.56

ROA %

-32.48 -6.87 -40.22 -48.66 -44.82 -62.00 -54.00 -63.68 -64.93 -72.62 -57.42 -65.41 -63.72 -31.04 -22.25 -28.44 -26.44 -23.39 -23.09 -24.47 -21.77 -18.91 -17.20 64.26 -95.07 -294.25 -551.12 -693.08 -616.68 -524.48 -407.16 -361.87 -324.22 -240.20 -124.32 -123.93 -99.20 -96.04 -92.76 -83.50 -73.34 -60.64 -50.62 -60.25 -91.14 -105.32 -124.62 -134.14 -125.23 -162.00 -157.35 -35.66 -60.61 -28.80

ROCE %

-481.66 -212.13 -180.52 -207.21 -171.24 -204.37 -142.05 -158.28 -147.82 -136.38 -106.07 -118.59 -114.87 -46.38 -33.58 -39.66 -36.73 -33.97 -33.22 -34.26 -29.76 -25.55 -23.78 -2.03 23.10 53.23 94.26 101.73 108.51 117.50 131.93 -8.48 -137.45 -298.37 -481.90 -422.05 -373.69 -304.42 -225.31 -184.39 -149.08 -110.57 -76.08 -128.92 -167.07 -198.53 -214.24 -610.86 -1042.36 -1497.16 -1939.24 -488.13 -504.75 -479.35

Current Ratio

1.6 2.0 1.1 1.3 1.4 1.2 1.4 1.6 1.6 2.1 2.3 2.5 2.7 3.1 2.6 2.6 2.6 2.6 2.7 2.7 2.7 2.7 2.3 2.3 2.3 2.3 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 1.2 1.2 1.2 1.2 1.7 1.7 1.7 1.7 2.9 2.9 2.9 2.9 2.4 2.4 2.4 2.4 1.1 1.1 1.1 1.1

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.8 5.5 1.7 98.6 - 101.9 33.6 42.5 - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.8 5.5 1.7 98.6 - 101.9 33.6 42.5 - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.8 5.5 1.7 98.6 - 101.9 33.6 42.5 - - - - - - - -

All numbers in USD currency